Artisan Partners Asset Management Inc. Reports 2Q18 Results

MILWAUKEE, July 31, 2018 (GLOBE NEWSWIRE) -- Artisan Partners Asset Management Inc. (NYSE: APAM) (the “Company” or “Artisan Partners”) today reported its results for the three and six months ended June 30, 2018.  The full June 2018 quarter earnings release and investor presentation can be viewed at www.apam.com.

Conference Call

The Company will host a conference call on August 1st, at 11:00 a.m. (Eastern Time) to discuss these results. Hosting the call will be Eric Colson, Chairman and Chief Executive Officer, and C.J. Daley, Chief Financial Officer. Supplemental materials that will be reviewed during the call are available on the Company’s website at www.apam.com. The call will be webcast and can be accessed via the Company’s website. Listeners may also access the call by dialing 877.328.5507 or 412.317.5423 for international callers; the conference ID is 10122159. A replay of the call will be available until August 8, 2018 at 9:00 a.m. (Eastern Time), by dialing 877.344.7529 or 412.317.0088 for international callers; the replay conference ID is 10122159. An audio replay will also be available on the Company’s website.

About Artisan Partners

Artisan Partners is a global investment management firm that provides a broad range of high value-added investment strategies to sophisticated clients around the world. Since 1994, the firm has been committed to attracting experienced, disciplined investment professionals to manage client assets. Artisan Partners’ autonomous investment teams oversee a diverse range of investment strategies across multiple asset classes. Strategies are offered through various investment vehicles to accommodate a broad range of client mandates.

Source: Artisan Partners Asset Management Inc.

Investor Relations Inquiries

Makela Taphorn
866.632.1770
414.908.2176
[email protected] 

You May Also Be Interested In

• Nvidia and Broadcom earnings: TD Cowen says earnings won’t settle big questions
• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Halozyme adds biotech executive Appelhans to its board